For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions, including neurocognitive and ...

Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

DPP-4 inhibitors improve your blood sugar without making it drop too low alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia) glucagon-like peptides ...

"I stopped using this as it has a fragrance on it that I didn't like." Another added: "I had big hopes for this peptides but I couldn't use it, I don't normally have sensitivity issues with face ...

“Zooming in to a 10,000-kilometer region, from a distance of 200 million light years, is like being able to measure the width of a DNA helix, which is about 2 nanometers wide, on the surface of ...

Here's a quick rundown: squalane and/or hyaluronic acid (HA) plump as well as hydrate, vitamin C protects against environmental stressors, peptides tighten, and retinol (also found in AHAs like ...

Department of Chemical Sciences and Center for Advanced Functional Materials, Indian Institute of Science Education and Research (IISER) Kolkata, Mohanpur 741246, West Bengal, India Institute for ...